Project Grant R35GM166027
- The National Institute of General Medical Sciences awarded the Board of Regents of the University of Nebraska $1,173,748 on July 10, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to support Phase 3 of the Nebraska Center for Integrated Biomolecular Communication (NCIBC). NCIBC advances understanding of biomolecular communication pathways that regulate cellular functions and coordinate intercellular actions, with application to disease mechanisms and targeted...
- The National Institute of General Medical Sciences awarded the Board of Regents of the University of Nebraska, through its University of Nebraska Medical Center division, $152,600 under the Biomedical Research and Research Training program (CFDA 93.859) on January 13, 2027, to fund a fellowship project examining the relationship between three-dimensional exon-exon DNA folding and RNA splicing. The research defines the mechanistic and temporal relationship between chromatin structure and...
- Federal Grant Award Summary The University of Nebraska Board of Regents received a $2.04 million Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded August 8, 2025, with completion targeted for July 31, 2029. This award supports fundamental research investigating the ARP2/3 complex—a critical protein assembly system essential to cellular processes including cell migration, tissue...
- The National Institute of General Medical Sciences awarded the Board of Regents of the University of Nebraska, through its University of Nebraska Medical Center division, $415,113 under the Biomedical Research and Research Training program (CFDA 93.859) on September 1, 2026. The award funds development of nanofiber-based sutures and dressings to reduce surgical site infections, treat wound biofilms, and promote chronic wound healing. The research builds on prior findings demonstrating successful...
- The National Institute of General Medical Sciences awarded the Board of Regents of the University of Nebraska $422,125 on July 15, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to support research on chromatin remodeling mechanisms across scales. The award funds investigation into how BAF, an ATP-dependent nucleosome remodeler, partners with distinct chromatin regulatory mechanisms to establish cell type-specific gene expression programs during development and...
- The National Institute of General Medical Sciences awarded Northeastern University $440,000 on July 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to discover novel antimicrobial molecules from clostridial biosynthesis. The project characterizes cobalamin-dependent radical S-adenosylmethionine enzymes fused with non-ribosomal peptide synthetase adenylation domains found in clostridial genomes. The recipient will conduct biochemical characterization of these...
- The National Institute of General Medical Sciences awarded $410,473 to the Regents of the University of Michigan on August 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to develop quantitative theory and computational models of collective cellular response to complex biophysical cues. The research encompasses two projects: investigation of swarming bacterial colonies' response to intestinal tissue cues in healthy and disease states, and analysis of...
- The National Institute of General Medical Sciences, part of the Department of Health and Human Services National Institutes of Health, awarded New York University $421,737 on March 10, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to develop data-driven, predictive biophysical models of molecular mechanisms underlying cellular quiescence in microorganisms. The research focuses on quantitative relations between physiological traits and molecular processes in...
- The National Institute of General Medical Sciences awarded the University of Chicago $451,000 on August 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to conduct systematic interrogation of diet as a mechanism to shape microbial community configuration and metabolism. The research examines how dietary macronutrients drive growth of specific microbial clades within a complex but defined human microbiome (HCOM2), utilizing in vitro analysis across a panel of...
- The National Institute of General Medical Sciences awarded Oklahoma State University $373,960 on September 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to support research on genome evolution and design in small, single-stranded DNA phages (Microviridae). The award is structured as a Project Grant with a period of performance running through August 31, 2031. Work is performed in Oklahoma City, Oklahoma. The National Institute of General Medical Sciences...
The National Institute of General Medical Sciences awarded $404,831 to the Board of Regents of the University of Nebraska on August 10, 2026, to develop a single-cell transcriptomic atlas for the formation and fate of microbial communities under the Biomedical Research and Research Training program (CFDA 93.859). The research addresses fundamental gaps in understanding how bacteria in microbial communities leverage genetic regulatory systems to coordinate the initiation of cellular heterogeneity and structure formation during community maturation, and how specific subpopulations ensure community persistence under harsh environmental stressors. The work employs a prokaryotic single-cell RNA sequencing approach called BASSSH-SEQ, which enables probing of the full transcriptomic space of resolved individual cells within microbial communities—overcoming prior technical limitations that restricted studies to either broad gene detection across populations or single-cell analysis but not both. The University of Nebraska Medical Center, the division of the recipient organization performing the work, is located in Omaha, Nebraska. The period of performance runs through April 30, 2031. This is a Project Grant, an assistance type under NIGMS that supports investigator-initiated biomedical research to advance fundamental scientific discoveries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $404.8k | 8/5/26 |